Reply to Ziesenitz, Victoria; Erb Thomas; Trachsel, Daniel; van den Anker Johannes, regarding their comment "Safety of dipryone (metamizole) in children-what's the risk of agranulocytosis?"
Paediatr Anaesth
.
2018 Mar;28(3):305-306.
doi: 10.1111/pan.13326.
Authors
Thomas G de Leeuw
1
,
Maaike Dirckx
1
2
,
Saskia N de Wildt
3
4
Affiliations
1
Department of Anesthesiology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.
2
Center for Pain Medicine, Erasmus MC, Rotterdam, The Netherlands.
3
Department of Pediatric Intensive Care and Pediatric Surgery, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.
4
Department of Pharmacology and Toxicology, Radboud University, Nijmegen, The Netherlands.
PMID:
29436141
DOI:
10.1111/pan.13326
No abstract available
Publication types
Letter
Comment
MeSH terms
Agranulocytosis*
Anti-Inflammatory Agents, Non-Steroidal
Child
Dipyrone*
Humans
Risk
Substances
Anti-Inflammatory Agents, Non-Steroidal
Dipyrone